Current/ Expected Orderbook/ Pending Orders?

The transcript does not provide specific details or figures regarding the current or expected order book or pending orders for Oriental Carbon & Chemicals Limited. Management discussed general growth and demand but did not disclose concrete order book data. The focus is on securing approvals and increasing allocations, especially in the North American market. They expect demand to improve and are working towards ramping up sales volumes. Mentioned inventory corrections and normalization of orders in Europe, indicating some volatility but no exact pending order figures. Growth in US and other r

Future growth expectations in sales/revenue/volumes?

The Company expects growth driven largely by the North American market, with significant turnover increases anticipated over the next 2-3 years as new approvals and allocations come through. Indian tire industry demand is strong, projected to triple in size over 10 years with a double-digit CAGR, supporting higher consumption of insoluble sulphur. Radialization trends in tires will increase insoluble sulphur consumption at a 1-2% higher rate than tire industry growth. Duncan Engineering business is in a growth phase, targeting 30% growth with new products, customers, and added personnel. Globa

Future growth expectations in earnings/operating earnings/profits/EPS?

Revenue growth: Q3 FY23 revenue grew 8% YoY; 9-month FY23 revenue grew 28% YoY, indicating healthy topline momentum. EBITDA growth: EBITDA increased 19% YoY in Q3 FY23 with 22.6% margin; 9-month EBITDA grew 6% YoY, suggesting operational improvement despite cost pressures. PAT: Q3 FY23 PAT was stable at Rs. 10.4 crores; 9-month PAT declined slightly to Rs. 32.2 crores due to margin impacts. Margins: EBITDA margins impacted by high raw material and freight costs; expected to improve as raw material prices and freight costs normalize. Volume growth: Expect volumes to recover with normalization i

AG Ventures LtdQ3 FY23Chemicals & Petrochemicals

AG Ventures Ltd Q3 FY23 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹129.2P/E: 5.7Market Cap: ₹128 CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

0 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

The Company expects growth driven largely by the North American market, with significant turnover increases anticipated over the next 2-3 years as new approvals and allocations come through.
Indian tire industry demand is strong, projected to triple in size over 10 years with a double-digit CAGR, supporting higher consumption of insoluble sulphur.
Radialization trends in tires will increase insoluble sulphur consumption at a 1-2% higher rate than tire industry growth.
Duncan Engineering business is in a growth phase, targeting 30% growth with new products, customers, and added personnel.
Global capacity utilization is around 70%, with no significant new capacity expansion expected that might oversupply the market.
Demand in Europe is stabilizing post-inventory correction, and Asia (other than China) is showing demand growth.
Expansion plans for capacity are on hold and will be revisited after 6 months based on market conditions.

Margin guidance

Category 3

Revenue growth: Q3 FY23 revenue grew 8% YoY; 9-month FY23 revenue grew 28% YoY, indicating healthy topline momentum.
EBITDA growth: EBITDA increased 19% YoY in Q3 FY23 with 22.6% margin; 9-month EBITDA grew 6% YoY, suggesting operational improvement despite cost pressures.
PAT: Q3 FY23 PAT was stable at Rs. 10.4 crores; 9-month PAT declined slightly to Rs. 32.2 crores due to margin impacts.
Margins: EBITDA margins impacted by high raw material and freight costs; expected to improve as raw material prices and freight costs normalize.
Volume growth: Expect volumes to recover with normalization in Europe and ramp-up in US market.
Market outlook: Indian tyre industry projected to grow at double-digit CAGR over 10 years; insoluble sulphur demand expected to grow slightly faster due to radialization.
Debt reduction: Term loans expected below Rs. 85 crores by September 2023, improving financial health and supporting growth.
Expansion: Second phase expansion deferred; to be reviewed post 6 months based on demand.

See what AG Ventures Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

- The company is actively reducing its debt, with long-term term loans expected to be below Rs. 85 crores by September 30, 2023. - They are repaying term loans early to save on interest costs. - No mention of any new fundraising through debt or equity in the current or near future. - The management is focused on comfortable debt levels to support growth and operations. - Plans to review expansion and funding needs after 6 months, indicating no immediate new fundraising. Overall, Oriental Carbon & Chemicals Limited is prioritizing debt reduction and free cash flow generation without indicating any immediate plans for raising new debt or equity capital.

Order book

The transcript does not provide specific details or figures regarding the current or expected order book or pending orders for Oriental Carbon & Chemicals Limited.
Management discussed general growth and demand but did not disclose concrete order book data.
The focus is on securing approvals and increasing allocations, especially in the North American market.
They expect demand to improve and are working towards ramping up sales volumes.
Mentioned inventory corrections and normalization of orders in Europe, indicating some volatility but no exact pending order figures.
Growth in US and other regions is expected but specific order quantities or values were not shared.
No direct commentary on order backlog or pipeline was referenced in the provided pages.

See what AG Ventures Ltd management said on order book — free account, 30 seconds.

Capex plans

- The company is currently not starting the second phase of expansion due to challenging sales and cost environment; the situation will be reviewed in the next 6 months. - Duncan Engineering is in a growth phase, focusing on adding more people, products, and customers, implying ongoing investment there. - There is no specific mention of new capital expenditure or strategic investments planned immediately in the call. - The company is focusing on debt reduction and improving free cash flow, which suggests cautious capital allocation. - No news of capacity expansion from competitors like Flexsys was mentioned, indicating a cautious industry outlook on capacity additions. Overall, near-term capital investments appear limited, with a focus on strategic growth via existing businesses and cautious evaluation of expansion plans.

Track AG Ventures Ltd — get its next earnings analysis in your feed

How does AG Ventures Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

ThisAG Ventures Ltd

Rev 3Mar 3

See where AG Ventures Ltd sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does AG Ventures Ltd rank in Chemicals & Petrochemicals?

Compare AG Ventures Ltd against every Chemicals & Petrochemicals company (Q3 FY23) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What AG Ventures Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

Neogen Chemicals Ltd (Q2 FY27)
Consolidated: ₹295.96 crore (up from ₹208.66 crore in Q3 FY25) . Key results statement takeaways from Neogen Chemicals Ltd's Q2 FY27 results statement — and how
Mahickra Chemicals Ltd (Q2 FY27)
682 million, a 34% year-on-year increase. Key results statement takeaways from Mahickra Chemicals Ltd's Q2 FY27 results statement — and how it ranks against sec
Vishnu Chemicals Ltd (Q2 FY27)
2,837.7 lakhs increase (~7.07% growth YoY). Key results statement takeaways from Vishnu Chemicals Ltd's Q2 FY27 results statement — and how it ranks against sec
Yasons Chemex (Q2 FY27)
4,927.35 lakhs for the same period in 2025, indicating a year-on-year decline of about 16.3% (Page 12). Key results statement takeaways from Yasons Chemex Care

Compare:vs Solar Industries vs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

AG Ventures Ltd Q3 FY23 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

How does AG Ventures Ltd rank in Chemicals & Petrochemicals?

Continue your research

What AG Ventures Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season